Concepedia

Bin‐Bing S. Zhou

BS

Statistics

Publications

32

Citations

3.3K

H-Index

23

Active since

1993

Affiliations

Shanghai Children's Medical Center(Current)

Shanghai Jiao Tong University

QIMR Berghofer Medical Research Institute

Incyte (United States)

St. Jude Children's Research Hospital

Bin‐Bing S. Zhou is an author at Shanghai Children's Medical Center specializing in molecular oncology, life sciences, and oncology.

ORCID

Publications per year

1993–2024

32

Publications

32

Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway

Priya Chaturvedi, Wai K Eng, Yuan Zhu et al. · Oncogene · 1999 · 424 citations

, , +15

Cdk1/Erk2- and Plk1-Dependent Phosphorylation of a Centrosome Protein, Cep55, Is Required for Its Recruitment to Midbody and Cytokinesis

Megan Fabbro, Bin‐Bing S. Zhou, Mikiko Takahashi et al. · Developmental Cell · 2005 · 341 citations · Full text

, , +13

Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia

Benshang Li, Samuel W. Brady, Xiaotu Ma et al. · Blood · 2019 · 301 citations · Full text

, , +16

Caffeine Abolishes the Mammalian G2/M DNA Damage Checkpoint by Inhibiting Ataxia-Telangiectasia-mutated Kinase Activity

Bin‐Bing S. Zhou, Priya Chaturvedi, Kevin J. Spring et al. · Journal of Biological Chemistry · 2000 · 278 citations · Full text

, , +16

Structural Basis for Chk1 Inhibition by UCN-01

Baoguang Zhao, Michael J. Bower, Patrick McDevitt et al. · Journal of Biological Chemistry · 2002 · 206 citations · Full text

, , +17

1–5 of 32